Month: October 2024

Participation notification by BNP Paribas Asset Management

Brussels, October 4, 2024, 08:30 CEST – Regulated information In line with Belgian transparency legislation (Law of May 2, 2007), BNP Paribas Asset Management Holding recently sent to Solvay the following transparency notification indicating that they crossed the threshold of 3%. Here is a summary of the notification:   Date on which the threshold was crossed Voting rights after the transaction Equivalent financial instruments after the transaction Total September 23, 2024 3.07% 0.00% 3.07%       The notification, dated October 02, 2024, contains the following information: Reason for the notification: acquisition or disposal of voting securities or voting rights Notified by: A parent undertaking or a controlling person Date on which the threshold is crossed: September 23, 2024 Threshold of...

Continue reading

Sampo plc’s share buybacks 3 October 2024

Sampo plc, stock exchange release, 4 October 2024 at 8:30 am EEST Sampo plc’s share buybacks 3 October 2024 On 3 October 2024, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                 Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)   4,250 41.61 AQEU           44,848 41.60 CEUX   761 41.72 TQEX   45,372 41.59 XHEL TOTAL 95,231 41.60   *rounded to two decimals                 On 17 June 2024, Sampo announced a share buyback programme of up to a maximum of EUR 400 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. On 16 September 2024, the Board of Directors of Sampo...

Continue reading

Darius Undzėnas becomes Chief Financial Officer of Novaturas Group

Novaturas Group, the leader in the Baltic tourism market, announces that Darius Undzėnas will take up the position of the company’s Chief Financial Officer (CFO) from October 7. With many years of comprehensive experience in financial management, Mr Undzėnas joins the Group’s top management team in Lithuania, Latvia and Estonia.  “We are confident that Darius’s diverse experience in finance and his management skills gained in international companies will contribute to the goal of strengthening the position of Novaturas in the tourism market. At the same time, we set a strategic goal for the new CFO – to strengthen the company’s financial position, which is important both for ensuring the long-term trust of our customers and partners and for creating long-term value for the company’s shareholders,” said Kristijonas Kaikaris, Chief Executive...

Continue reading

Valneva SE – Declaration of shares and voting rights – September 30, 2024

VALNEVA Declaration of shares and voting rights September 30, 2024__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris – Compartment B Declaration date: October 4, 2024 Number of shares composing the share capital of Valneva Total number of voting rights including suspended voting rights* Description of the change Date on which this change was recognized Total number of voting rights excluding suspended voting rights**     162,276,901   ordinary shares with a par value of €0.15 each 178,144,731 Transfer into bearer form of 750,000 shares with double voting rights   Capital increase without preferential subscription rights (23,000,000 new ordinary shares issued)   Double...

Continue reading

Daimler Truck North America and Hexagon Purus end supply agreement for battery electric vocational vehicles

(4 October 2024 – Oslo, Norway) Reference is made to the stock exchange release by Hexagon Purus ASA (“Hexagon Purus” or the “Company”) on 14 August 2023, where Hexagon Purus and Daimler Truck North America (“DTNA”) signed a long-term agreement for complete vehicle integration of battery electric vocational vehicles. The parties have today mutually agreed to terminate the 2024-2027 supply agreement, and DTNA will reimburse Hexagon Purus for certain costs that the Company has undertaken related to this agreement. The decision unlocks capacity to address other near-term opportunities for strategically attractive battery electric commercial vehicle programs with higher volume and margin potential. It also enables the Company to enhance its focus on the operational execution and scale-up of its long-term agreement for the supply of battery...

Continue reading

RECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO®, STRENGTHENING ITS RARE DISEASES FRANCHISE

    Milan, 4th October 2024 – Recordati today announces an agreement with Sanofi to acquire the global rights to Enjaymo® (sutimlimab), a biologic which is the only approved targeted product for the treatment of cold agglutinin disease (CAD), a rare B-cell lymphoproliferative disorder. Enjaymo® (sutimlimab) is a humanized monoclonal antibody indicated for the treatment of hemolysis in adults with CAD. In 2022, it was granted approval by the U.S. Food and Drug Administration (FDA), the European Commission (EC) and the Japanese Ministry of Health, Labor and Welfare. Administered as chronic IV treatment, Enjaymo® addresses a serious unmet medical need in patients with CAD. Financial highlightsEnjaymo® generated approximately € 100 million in revenue over the last 12 months as of August 2024 and is expected to generate revenue in excess...

Continue reading

Conclusion of share repurchase programme

On 3 June 2024, Jyske Bank initiated a share repurchase programme that was to be concluded on 31 January 2025 at the latest. In this period, Jyske Bank would acquire shares with a value of up to DKK 1.5 billion, cf. Corporate Announcement No. 12/2024 of 7 May 2024. The share repurchase programme was initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014, the so-called “Market Abuse Regulation”. Following the transactions stated below, own shares worth DKK 1.5 billion have been repurchased and the programme has been concluded:   Number of shares Average purchase price (DKK) Transaction value (DKK) Accumulated, previous announcement 2,717,007 542.94 1,475,177,479 30 September 2024 60 523.26 31,396 1 October 2024 20,291 516.35 10,477,162 2 October...

Continue reading

Molecular Partners Announces upcoming poster presentations at the 2024 SITC Annual Meeting

Preclinical proof-of-concept data supports CD3 Switch-DARPin platform for T cell engagers with enhanced function in solid tumors Biomarker data on completed phase 1 study of MP0317 (FAP x CD40) shows intended and marked tumor microenvironment modulation ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced that the Company will introduce proof-of-concept data for its new CD3 Switch-DARPin designed to overcome current T cell engager challenges in solid tumors, as well as present additional analyses from its Phase 1 study of MP0317 in patients with advanced solid tumors, at the 2024 Annual Meeting of the Society for Immunotherapy...

Continue reading

ALSTOM SA: Alstom Preview Note – Q2 and H1 2024/25 Preview

Alstom Note – Q2 and H1 2024/25 Preview 4 October 2024 – Alstom presents below a preview to its Q2 and H1 2024/25 results. Q2 2024/25 orders The table below summarizes the large orders (more than €200m) published and booked during the quarter. Orders   Value(in € million) Description Link to press release Proxima ~850 France – 12 very High speed trains with 15Y maintenance Link to the PR   S-Bahn Köln ~3,600 Germany – Frame agreement of 90 trains and 34 years maintenance for ~4bn, o/w ~3.6bn to be booked in Q2, and the rest at a later stage (options) Link to the PR   Perth – Signalling ~650 Western Australia – High capacity signalling project Link to the PR   Total large orders ~5,100     Deals announced previously, but to be booked at a later stage Haifa-Nazareth Systems contract for ~€700m, expected booking in...

Continue reading

TGS Webcast Details for Q3 2024 Presentation

Oslo, Norway (4 October 2024) – TGS, a leading global provider of energy data and intelligence will release its Q3 2024 results at approximately 07:00 a.m. CEST on 24 October 2024. CEO Kristian Johansen and CFO Sven Børre Larsen will present the results at 09:00 a.m. CEST at House of Oslo, Ruseløkkveien 34 in Oslo, Norway. The presentation is open to the public and will be webcasted live. Access and registration for webcast attendees are available by copying and pasting the link below into your browser, or use the link on the front page of www.tgs.com: https://channel.royalcast.com/landingpage/hegnarmedia/20241024_5/ The Q3 2024 earnings release and presentation will be available on www.newsweb.no and www.tgs.com. For more information, visit TGS.com (http://www.tgs.com) or contact: Bård Stenberg, VP IR & Communication Mobile:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.